Results 71 to 80 of about 3,833 (193)

Reduced intensity treatment in early-stage Hodgkin’s lymphoma

open access: yesBlood and Lymphatic Cancer: Targets and Therapy, 2011
Prathima Prodduturi, James O ArmitageUniversity of Nebraska Medical Center, Omaha, NE, USAAbstract: Early-stage Hodgkin’s lymphoma which includes patients with Ann Arbor stages I or II, accounts for more than 50% of all cases of the illness and
Armitage JO, Prodduturi P
doaj  

Induction of Apoptosis by 2', 3’-Epoxyisocapnolactone and 8-Hydroxyisocapnolactone-2', 3’- Diol Isolated from Micromelum Minutum in Human T-Lymphocyte Leukemia Cem-Ss Cells [PDF]

open access: yes, 2006
2',3'-epoxyisocapnolactone and 8-hydroxyisocapnolactone-2',3'-diol are two bioactive compounds isolated from the leaves of Mzcromelum minutum. The cytotoxic effect of the compounds was tested on a variety of human cell lines respectively using MTT ...
Tan, Boon Keat
core  

Chemical mutagenesis [PDF]

open access: yes, 2012
The first attempts to induce mutations in biological systems using chemical compounds go back to the beginning of the past century. However, it was during World War II that the two most relevant names in chemical mutagenesis, Charlotte Auerbach and ...
Leitão, José
core  

Malignant glioma: Should chemotherapy be overthrown by experimental treatments? [PDF]

open access: yes, 2017
Despite more than two decades of clinical research with chemotherapy, the outcome of malignant gliomas remains poor. Recent years have seen major advances in elucidation of the biology of these tumors, which in turn have led to the current development of
de Tribolet, N.   +3 more
core  

CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease - A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL) [PDF]

open access: yes, 1996
Purpose. To test the adequacy of the CVPP four-drug regimen as ancillary chemotherapy associated with extended-field radiotherapy in the treatment of early, unfavorable, clinically staged Hodgkin's disease. Patients and Methods.
Angrilli, F   +11 more
core  

Index of pretreatment intensity predicts outcome of high-dose chemotherapy and autologous progenitor cell transplantation in chemosensitive relapse of Hodgkin's disease [PDF]

open access: yes, 2017
Purpose To identify prognostic factors in patients with chemosensitive relapsed Hodgkin's disease treated by high-dose chemotherapy with autologous progenitor cell transplantation (HDC) and to compare the duration of treatment-free remission prior to HDC
Honegger, H. P.   +3 more
core  

Hodgkin's disease presenting below the diaphragm. The experience of the Gruppo Italiano Studio Linfomi (GISL) [PDF]

open access: yes, 1997
Background and Objective. Infradiaphragmatic Hodgkin\ub4s disease is rare, making up 5-12% of cases in clinical stages I and II; consequently, several questions concerning prognosis and treatment strategy remain to be answered.
Accurso, V   +9 more
core  

EVALUASI PENGGUNAAN ANTIEMETIKA PADA PASIEN KANKER NASOFARING DENGAN KEMOTERAPI DI INSTALASI RAWAT INAP RSUD Dr MOEWARDI SURAKARTA TAHUN 200 [PDF]

open access: yes, 2010
Penggunaan obat kemoterapi dapat menyebabkan mual dan muntah, obat kemoterapi pada kanker nasofaring merupakan obat dengan emetogenisitas tinggi dan sedang. Efek ini dapat menurunkan efektivitas penggunaan kemoterapi bila tidak ditangani dengan tepat.
RAHAYU , PRIYANTI
core  

Unravelling the role of SNM1 in the DNA repair system of Trypanosoma brucei [PDF]

open access: yes, 2015
Ali, S   +11 more
core   +1 more source

Nurses\u27 Alumnae Association Bulletin - Volume 17 Number 1 [PDF]

open access: yes, 1952
Alumnae Notes Committee Reports Digest of Alumnae Association Meetings Greetings from Miss Childs Greetings from the Educational Director Greetings from the President Graduation Awards - 1951 Jefferson\u27s New Hospital Addition Marriages Necrology ...
Alpers, Bernard J   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy